To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
VC-backed CinCor prices IPO
CinCor Pharma, a developer of treatment for hypertension and other cardio-renal diseases, has priced its IPO of 11 million shares at a price range between $15 and $17 per share.
